US$ 25.31
dpp-4 inhibitors vs. glp-1 agonist Receptor Agonists Have better Outcomes Than DPP4 in T2D patients & CKD Mechanisms of dipeptidyl peptidase‐4 (DPP‐4)
Description
doi: 10.1016/j.jalz.2013.12.007 [DOI] [PMC free article] [PubMed] [Google Scholar] 2

doi: 10.1016/j.ejphar.2015.09.024 186 SonH.BanasrM.ChoiM.ChaeS

How do GLP-1 medications differ from other weight loss options

Drugs like Semaglutide (Ozempic, Wegovy) and Liraglutide (Saxenda, Victoza) are not only changing the way we manage Type 2 Diabetes but also making waves in the weight-loss industry

Pharmacogenetics of glucagon-like peptide-1 agonists for the treatment of type 2 diabetes mellitus
